Literature DB >> 3771519

Fibronectin-binding properties of the purified platelet glycoprotein IIb-IIIa complex.

L V Parise, D R Phillips.   

Abstract

Fibronectin binds to specific receptors on the surface of washed, thrombin-activated platelets. Evidence suggests that these receptors are closely associated with the platelet glycoprotein IIb-IIIa complex (GP IIb-IIIa). To determine whether GP IIb-IIIa itself can form a platelet receptor for fibronectin, we used a filtration assay to examine the interaction of purified fibronectin with purified GP IIb-IIIa incorporated into phospholipid vesicles. 125I-Fibronectin binding to the phospholipid vesicles required the presence of incorporated GP IIb-IIIa and was specific, time-dependent, reversible, saturable, and divalent cation-dependent (Mg2+ greater than Ca2+). The dissociation constant for 125I-fibronectin binding to the GP IIb-IIIa-containing vesicles in the presence of 2 mM MgCl2 was 87 nM. Proteins or peptides that inhibit 125I-fibronectin binding to whole platelets also inhibited 125I-fibronectin binding to the GP IIb-IIIa vesicles. Thus, specific 125I-fibronectin binding was inhibited by excess unlabeled fibrinogen or fibronectin, the anti-GP IIb-IIIa monoclonal antibody 10E5, the decapeptide from the carboxyl terminus of the fibrinogen gamma-chain, and the tetrapeptide Arg-Gly-Asp-Ser from the cell-binding domain of fibronectin. In contrast to results obtained using whole platelets, unlabeled fibronectin inhibited 125I-fibronectin binding to the GP IIb-IIIa vesicles. These results show that 125I-fibronectin binds directly to purified GP IIb-IIIa with most of the previously reported properties of 125I-fibronectin binding to washed, thrombin-stimulated platelets. Thus, GP IIb-IIIa has the potential to function as a platelet receptor for fibronectin as well as for fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771519

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

Review 2.  Interaction of the cytoskeleton with the plasma membrane.

Authors:  V Niggli; M M Burger
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

3.  Human Plasma Fibronectin Mediates Adhesion of U937 Cells by RGD and CS1.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

4.  Phorbol ester modulation of integrin-mediated cell adhesion: a postreceptor event.

Authors:  Y N Danilov; R L Juliano
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

5.  Evidence that an RGD-dependent receptor mediates the binding of oligodendrocytes to a novel ligand in a glial-derived matrix.

Authors:  M C Cardwell; L H Rome
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

6.  An interaction between alpha-actinin and the beta 1 integrin subunit in vitro.

Authors:  C A Otey; F M Pavalko; K Burridge
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

7.  Amino acid sequence of the human fibronectin receptor.

Authors:  W S Argraves; S Suzuki; H Arai; K Thompson; M D Pierschbacher; E Ruoslahti
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

8.  Effects of feeding periods of high cholesterol and saturated fat diet on blood biochemistry and hydroxyproline fractions in rabbits.

Authors:  Mohamed A K Abdelhalim; N J Siiddiqi; A S Alhomida; Mohammed S Al-Ayed
Journal:  Bioinform Biol Insights       Date:  2008-04-22

Review 9.  Integrins.

Authors:  Malgorzata Barczyk; Sergio Carracedo; Donald Gullberg
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

10.  Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets.

Authors:  M E Bertagnolli; M C Beckerle
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.